60483_BioElectronis.jpg
BioElectronics President’s Response to Stock Price Decline
04 déc. 2018 08h30 HE | BioElectronics Corporation
Frederick, Maryland, Dec. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Dear Fellow Shareholders, While we were all disappointed by the dramatic drop in the stock price, it hasn’t had an...
60483_BioElectronis.jpg
BioElectronics Announces FDA Market Clearance Update
27 nov. 2018 09h31 HE | BioElectronics Corporation
FREDERICK, MD, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC Pink: BIEL), the maker of non-invasive electroceutical devices, announced that the U.S. Food...
60483_BioElectronis.jpg
BioElectronics Signs a Five Country Additional Distribution Agreement with Mundipharma Pty Limited, South East Asia
15 nov. 2018 08h30 HE | BioElectronics Corporation
FREDERICK, MD, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that Mundipharma Pty Limited, has added the...
60483_BioElectronis.jpg
BioElectronics Announces Publication of Electroceuticals Article on Chronic Pain
04 oct. 2018 08h30 HE | BioElectronics Corporation
FREDERICK, MD, Oct. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC Pink: BIEL), the maker of non-invasive electroceutical devices, announced the publication of an...
60483_BioElectronis.jpg
BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program
13 août 2018 07h30 HE | BioElectronics Corporation
FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug...
60483_BioElectronis.jpg
BioElectronics ActiPatch Musculoskeletal Therapy Added to Mundipharma Australia's Pain Portfolio
23 juil. 2018 08h30 HE | BioElectronics Corporation
FREDERICK, MD, July 23, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that Mundipharma Pty Limited (Mundipharma),...
60483_BioElectronis.jpg
BioElectronics Files FDA Application for Treatment of Musculoskeletal Pain
12 juil. 2018 08h30 HE | BioElectronics Corporation
FREDERICK, MD, July 12, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that a Traditional 510(k) Premarket Notification for ActiPatch®...
60483_BioElectronis.jpg
B. Braun Medical Includes BioElectronics ActiPatch Medical Device In Its Same Day Knee and Hip Surgical Program
31 mai 2018 08h00 HE | BioElectronics Corporation
FREDERICK, MD., May 31, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), maker of advanced medical devices announces that B. Braun Ltd, of Sheffield, UK has recently completed...
60483_BioElectronis.jpg
BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application
29 mai 2018 11h48 HE | BioElectronics Corporation
FREDERICK, MD, May 29, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com reports that it has cancelled today’s scheduled US Food and Drug Administration meeting....
60483_BioElectronis.jpg
BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Application
11 mai 2018 08h30 HE | BioElectronics Corporation
FREDERICK, MD , May 11, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to report on the outcome of its Pre-Submission meeting on May 9th, 2018 with...